Next |
home / stock / adxs / adxs message board
Subject | By | Source | When |
---|---|---|---|
The only safe haven for $$$$ these days | hdwrsft | investorshub | 03/22/2023 5:15:04 PM |
What a turd. CEO Ken is running this | Ryguy008 | investorshub | 03/20/2023 2:35:37 PM |
Another massive bank shockingly failed. One day it's | hdwrsft | investorshub | 03/12/2023 6:03:14 AM |
Just think, in just another 7 years, and | hdwrsft | investorshub | 02/14/2023 2:26:10 PM |
If there is any justice in this universe, | HereToFightScams | investorshub | 01/11/2023 4:23:53 AM |
Looks like things are picking up we may | carp77 | investorshub | 01/09/2023 7:50:00 PM |
Well its certainly been a learning experience. I | James salmon | investorshub | 01/05/2023 9:16:35 PM |
James, Are you as broke as I am | oakrock | investorshub | 01/04/2023 2:19:13 AM |
Hmm (Glancing at the EOY PPS). Some things | hdwrsft | investorshub | 12/27/2022 8:04:25 PM |
Them pesty R/S's pop up quicker than weeds | hdwrsft | investorshub | 12/22/2022 10:40:59 PM |
Waiting patiently for the next 20 for 1 | ADXSINC | investorshub | 12/22/2022 9:47:10 PM |
Crickets. | hdwrsft | investorshub | 12/22/2022 5:04:45 PM |
I see alot of same names (fellow bag | Traderbx | investorshub | 12/17/2022 10:16:01 PM |
The last of someones FTX crypto currency investdonation......? | hdwrsft | investorshub | 12/15/2022 10:20:40 PM |
Salmon man adding? | girlfriend | investorshub | 12/15/2022 10:17:35 PM |
That was blue eyes, she is still buying | ADXSINC | investorshub | 12/15/2022 10:15:16 PM |
Volume posted this early AM: 1 Totally laughable. | hdwrsft | investorshub | 12/15/2022 2:47:46 PM |
Not sure what data you are referring to. | ubmmg | investorshub | 12/13/2022 10:15:07 PM |
Hi Nick, | phytokaiser1 | investorshub | 12/07/2022 10:19:48 PM |
I'm hearing a lot of chatter about psylocybin | Nickwvt | investorshub | 12/07/2022 4:49:27 PM |
News, Short Squeeze, Breakout and More Instantly...
MONMOUTH JUNCTION, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that it filed a Form 15 with the Securities and Exchange Commission (the “SEC”) to deregister its common stock under Section 12(g) ...
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM). As per the ...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that patient enrollment has been completed in the Phase 3 RINGSIDE study evaluating AL102 in desmoid tumors. A total of 156 ...